Average Co-Inventor Count = 6.86
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Boehringer Ingelheim Pharmaceuticals, Inc. (32 from 276 patents)
2. Boehringer Ingelheim International Gmbh (14 from 1,535 patents)
3. Boehringer Ingelheim Pharma Gmbh & Co Kg (194 patents)
46 patents:
1. 8829034 - Compounds which modulate the CB2 receptor
2. 8741897 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
3. 8383615 - Azetidine 2-carboxamide derivatives which modulate the CB2 receptor
4. 8362039 - Therapeutic uses of compounds which selectively modulate the CB2 receptor
5. 8349871 - Therapeutic uses of compounds which selectively modulate the CB2 receptor
6. 8299111 - Compounds which modulate the CB2 receptor
7. 8268859 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
8. 8263597 - Indazole compounds as CCR1 receptor antagonists
9. 8212040 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and thereof
10. 8173638 - Compounds which modulate the CB2 receptor
11. 8048899 - Compounds which selectively modulate the CB2 receptor
12. 8008327 - Indazole compounds as CCR1 receptor antagonists
13. 7935715 - Compounds which modulate the CB2 receptor
14. 7932392 - Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
15. 7928103 - Compounds which modulate the CB2 receptor